一覧に戻る

タイトル
  • en Transient subacute cerebellar ataxia in a patient with Lambert-Eaton myasthenic syndrome after intracranial aneurysm surgery
作成者
    • en Nakamura, Masakazu
    • en Sato, Kazunori
    • en Nakano, Fumihito
    • en Yaguchi, Hiroaki
    • en Tsuji, Sachiko
    • en Shiraishi, Hirokazu
    • en Yoneda, Makoto
    • en Tanaka, Keiko
    • en Motomura, Masakatsu
アクセス権 open access
主題
  • NDC 493
内容注記
  • Abstract en Several reports have presented patients with subacute cerebellar ataxia (subacute CA) and Lambert-Eaton myasthenic syndrome (LEMS). Some clinical features of those patients have been described in the previous reports, such as priority of subacute CA to LEMS or a concurrent occurrence of both diseases, a high incidence of malignancy, less efficacy of the treatment for subacute CA compared with that for LEMS. Cerebellar ataxia in some patients with LEMS has been demonstrated to be caused by serum antibodies to P/Q-type voltage-gated calcium channels (VGCCs). Here, we report a 63-year-old woman with subacute CA and LEMS. Cerebellar ataxia appeared 15 months after the incidence of LEMS, and the onset of cerebellar ataxia was thought to be due to serum anti-P/Q-type VGCCs antibodies. The clinical course of this patient was atypical in that 1) LEMS preceded subacute CA which developed after intracranial aneurysm surgery, 2) no malignancy was detected when both diseases coexisted, 3) symptoms of LEMS did not progress with the onset of cerebellar ataxia, and 4) cerebellar ataxia showed a definite improvement in symptoms and by 123I-IMP SPECT imaging after steroid administration. In addition, it is remarkable that LEMS became aggravated in electrophysiological examinations in contrast to subacute CA. We suggest that these atypical features of subacute CA and the changes in LEMS may be associated with a balance between the amount of serum anti-P/Q-type VGCCs antibodies and the susceptibility of the cerebellum and presynaptic nerve terminals to the antibodies. More cases are needed to investigate the mechanisms involved. The subacute CA and LEMS in this patient have remained comparatively silent after the withdrawal of steroid, and we are continuing to observe her condition.
出版者 en Elsevier
日付
    Issued2008-05
言語
  • eng
資源タイプ journal article
出版タイプ AM
資源識別子 HDL http://hdl.handle.net/2115/33929
関連
  • URI http://www.sciencedirect.com/science/journal/03038467
  • isVersionOf DOI https://doi.org/10.1016/j.clineuro.2008.01.002
  • PMID 18295972
収録誌情報
    • PISSN 0303-8467
      • en Clinical Neurology and Neurosurgery
      • 巻110 号5 開始ページ480 終了ページ483
ファイル
    • fulltext yabe.pdf
    • 341.34 KB (application/pdf)
      • Issued2008-05
コンテンツ更新日時 2023-07-26